Biogen's Desperate & Possibly Illegal Attempt to Improve Tecfidera Sales By Reaching Out to Consumers and Patients Directly
admin
April 28, 2016
It seems that $8.3 Bn in worldwide sales of Biogen's MS drug Tecfidera is not enough to satisfy Biogen's investor overlords. For the...
Biogen's Desperate & Possibly Illegal Attempt to Improve Tecfidera Sales By Reaching Out to Consumers and Patients Directly
Reviewed by admin
on
April 28, 2016
Rating:
Reviewed by admin
on
April 28, 2016
Rating:
